SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-024245
Filing Date
2017-10-16
Accepted
2017-10-16 17:03:45
Documents
1
Period of Report
2017-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 35325
  Complete submission text file 0000899243-17-024245.txt   36743
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SCICLONE PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404
Business Address
Cheung Wilson Wai-Shun (Reporting) CIK: 0001291656 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 171139289